Sasco Capital Inc. CT Increases Stock Holdings in Clarivate Plc (NYSE:CLVT)

Sasco Capital Inc. CT increased its holdings in Clarivate Plc (NYSE:CLVTFree Report) by 160.6% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,472,280 shares of the company’s stock after buying an additional 2,140,050 shares during the period. Clarivate comprises about 3.0% of Sasco Capital Inc. CT’s holdings, making the stock its 16th largest position. Sasco Capital Inc. CT owned about 0.51% of Clarivate worth $23,299,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Banque Cantonale Vaudoise acquired a new position in shares of Clarivate during the 3rd quarter worth approximately $33,000. Tower Research Capital LLC TRC raised its holdings in shares of Clarivate by 201.5% in the second quarter. Tower Research Capital LLC TRC now owns 4,682 shares of the company’s stock worth $45,000 after acquiring an additional 3,129 shares during the last quarter. Macquarie Group Ltd. lifted its position in shares of Clarivate by 40.5% in the first quarter. Macquarie Group Ltd. now owns 6,077 shares of the company’s stock valued at $57,000 after acquiring an additional 1,753 shares in the last quarter. Forum Financial Management LP acquired a new stake in shares of Clarivate during the third quarter valued at $81,000. Finally, Penserra Capital Management LLC increased its position in Clarivate by 50.0% during the 1st quarter. Penserra Capital Management LLC now owns 5,322 shares of the company’s stock worth $89,000 after purchasing an additional 1,774 shares in the last quarter. Hedge funds and other institutional investors own 86.52% of the company’s stock.

Clarivate Trading Up 0.8 %

NYSE:CLVT traded up $0.07 on Thursday, hitting $9.29. 2,221,644 shares of the stock were exchanged, compared to its average volume of 3,287,154. The stock has a market cap of $6.17 billion, a PE ratio of 35.50, a PEG ratio of 1.31 and a beta of 1.32. Clarivate Plc has a fifty-two week low of $6.07 and a fifty-two week high of $11.99. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.92. The stock has a fifty day moving average of $8.85 and a 200-day moving average of $7.76.

Clarivate (NYSE:CLVTGet Free Report) last posted its earnings results on Tuesday, November 7th. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.03. The firm had revenue of $647.20 million during the quarter, compared to the consensus estimate of $631.41 million. Clarivate had a net margin of 9.77% and a return on equity of 9.47%. The company’s revenue was up 1.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.18 EPS. As a group, equities analysts expect that Clarivate Plc will post 0.62 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Oppenheimer raised their price target on shares of Clarivate from $10.00 to $11.00 and gave the stock an “outperform” rating in a research note on Monday, January 8th. Jefferies Financial Group upgraded Clarivate from a “hold” rating to a “buy” rating and cut their price target for the company from $10.00 to $8.50 in a report on Monday, October 16th. Finally, Wells Fargo & Company restated an “underweight” rating and set a $8.00 price objective on shares of Clarivate in a report on Friday, December 15th. Three analysts have rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company. According to, the stock presently has a consensus rating of “Hold” and an average target price of $8.33.

View Our Latest Report on Clarivate

Clarivate Profile

(Free Report)

Clarivate Plc, an information, analytics, and workflow company, provides structured information and analytics for discovery, development, protection, commercialization, and measurement of scientific research, innovations, and brands. The company operates through three segments: Academia and Government, Life Sciences and Healthcare, and Intellectual Property.

Further Reading

Want to see what other hedge funds are holding CLVT? Visit to get the latest 13F filings and insider trades for Clarivate Plc (NYSE:CLVTFree Report).

Institutional Ownership by Quarter for Clarivate (NYSE:CLVT)

Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with's FREE daily email newsletter.